Financials data is unavailable for this security.
View more
Year on year Bio-Techne Corp 's net income fell -41.07% from 285.26m to 168.11m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 30.83% to 33.77%.
| Gross margin | 66.41% |
|---|---|
| Net profit margin | 14.50% |
| Operating margin | 17.83% |
| Return on assets | 6.29% |
|---|---|
| Return on equity | 8.33% |
| Return on investment | 6.65% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Bio-Techne Corp fell by 28.78m. However, the company earned 298.98m from its operations for a Cash Flow Margin of 25.80%. In addition the company used 203.03m on investing activities and also paid 122.40m in financing cash flows.
| Cash flow per share | 1.74 |
|---|---|
| Price/Cash flow per share | 45.56 |
| Book value per share | 13.08 |
|---|---|
| Tangible book value per share | 3.72 |
More ▼
Balance sheet in USDView more
| Current ratio | 3.87 |
|---|---|
| Quick ratio | 2.75 |
| Total debt/total equity | 0.1542 |
|---|---|
| Total debt/total capital | 0.1336 |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 0.40% |
|---|---|
| Div growth rate (5 year) | 0.00% |
| Payout ratio (TTM) | 30.00% |
| EPS growth(5 years) | 11.13 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -40.58 |
More ▼
